Similar articles

• Providers of ESRD therapy.

  [No authors listed] [No authors listed] Am J Kidney Dis. 1991 Nov;18(5 Suppl 2):89-92. Am J Kidney Dis. 1991. PMID: 1951361 No abstract available.
• Evolution of recombinant human erythropoietin usage in clinical practice in the United States. Is there an optimal way to use rHuEPO?

  Besarab A, McCrea JB. Besarab A, et al. ASAIO J. 1993 Jan-Mar;39(1):11-8. ASAIO J. 1993. PMID: 8439674 Review. No abstract available.
• XI. Annual facility survey of providers of ESRD therapy.

  [No authors listed] [No authors listed] Am J Kidney Dis. 1999 Aug;34(2 Suppl 1):S140-3. doi: 10.1053/AJKD034s00140. Am J Kidney Dis. 1999. PMID: 10431010 No abstract available.
• Hospitalization for dialysis patients.

  [No authors listed] [No authors listed] Am J Kidney Dis. 1991 Nov;18(5 Suppl 2):74-8. Am J Kidney Dis. 1991. PMID: 1951359 No abstract available.
• Anemia and erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.

  Korbet SM. Korbet SM. Kidney Int Suppl. 1993 Feb;40:S111-9. Kidney Int Suppl. 1993. PMID: 8445832 Review. No abstract available.